ANI Pharmaceuticals Competitors and Similar CompaniesClear all

ANI Pharmaceuticals's competitors and similar companies include Dermavant Sciences and Merus.
ANI Pharmaceuticals
ANI Pharmaceuticals
ANI Pharmaceuticals develops, manufactures and markets top quality prescription pharmaceuticals, made in the U.S.A.
Dermavant Sciences
Dermavant Sciences
Dermavant Sciences, a clinical-stage biopharmaceutical company, develops and commercializes therapeutics in medical dermatology.
Merus
Merus
Merus is a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics with the goal of treating and potentially curing cancer patients.
Founding Date
Founding Date
1996
Founding Date
2016
Founding Date
2003
Type
Type
Public
Type
Subsidiary
Type
Public
Tags
Locations
Locations
Baudette, US HQ
Oakville, CA
Baudette, US
Locations
Long Beach, US HQ
Basel, CH
Durham, US
Morrisville, US
New York, US
Phoenix, US
Locations
Utrecht, NL HQ
Cambridge, US
Employees
Employees
33813% increase
Employees
3021% decrease
Employees
1725% increase
Valuation ($)
Valuation ($)
1.4 b
Valuation ($)
N/A
Valuation ($)
2.5 b

Financial

Revenue (est.)
Revenue (est.)
$486.8m (FY, 2023)
Revenue (est.)
N/A
Revenue (est.)
$41.6m (FY, 2022)
Net income
Net income
$18.8m (FY, 2023)
Net income
($255.3m) (FY, 2019)
Net income
($131.2m) (FY, 2022)

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
$ 200m
Total funding raised
$ 149.3m
For sources of this data, please see the company profile

View Company Profiles

Dermavant Sciences
HQ
Long Beach, US

Dermavant Sciences, a clinical-stage biopharmaceutical company, develops and commercializes therapeutics in medical dermatology.

View company
Merus
HQ
Utrecht, NL
Employees
172↑ 5% increase

Merus is a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics with the goal of treating and potentially curing cancer patients.

View company